The N3C offers one of the largest collections of secure and deidentified clinical data in the United States for COVID-19 research. Its ever-growing size and capabilities allow researchers and clinicians to study COVID-19 health outcomes. N3C represents a shared vision for turning real-world data into the knowledge needed to address COVID-19 as the pandemic evolves.
-
Research
-
- Funding & Notices
-
National COVID Cohort Collaborative (N3C)
N3C Data Show Paxlovid Cut COVID-19 Hospitalization Risk, but Treatment Disparities Emerge
In a preprint study, researchers using the N3C Data Enclave found that patients who took Paxlovid within five days of a COVID-19 diagnosis were 65% less likely to be hospitalized.
About the ProgramLearn about the N3C.
N3C Forms and ResourcesCentralized location for links to documents, resources and other material related to the N3C.
Learn about the N3C.
Centralized location for links to documents, resources and other material related to the N3C.
Contact
If you have questions about the N3C, please email NCATS_N3C@nih.gov.
- Funding & Notices
-